Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia

Atherosclerosis

Volumn 242, Issue 1, 2015, Pages 226-229

  Bos, Sven ^a   Duvekot, Martijne H C ^a   Touw Blommesteijn, Adriana C ^a   Verhoeven, Adrie J M ^a   Mulder, Monique T ^a   Watts, Gerald F ^b   Sijbrands, Eric J G ^a   Roeters van Lennep, Jeanine E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Carotid intima media thickness; Carotid plaque presence; Familial hypercholesterolemia; Lipoprotein (a); Residual risk

Indexed keywords

ATORVASTATIN; LIPOPROTEIN A; ROSUVASTATIN; SIMVASTATIN; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; ECHOGRAPHY; EXTERNAL CAROTID ARTERY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; HUMAN; INTERNAL CAROTID ARTERY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RIGHT COMMON CAROTID ARTERY; THERAPY DELAY; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY; CAROTID ARTERY DISEASES; COMPARATIVE STUDY; HYPERLIPOPROTEINEMIA TYPE II; NETHERLANDS; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

ADULT; BIOMARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEIN(A); MALE; MIDDLE AGED; NETHERLANDS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84938099386     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.07.024     Document Type: Article

References (25)

1. Brown M.S., Goldstein J.L. Areceptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
2. Rader D.J., Cohen J., Hobbs H.H. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J.Clin. Invest. 2003, 111:1795-1803.
3. Soutar A.K., Naoumova R.P. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4:214-225.
4. Umans-Eckenhausen M.A., Sijbrands E.J., Kastelein J.J., Defesche J.C. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation 2002, 106:3031-3036.
5. Neefjes L.A., Ten Kate G.J., Alexia R., et al. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia. Atherosclerosis 2011, 219:721-727.
6. Vuorio A., Docherty K.F., Humphries S.E., et al. Statin treatment of children with familial hypercholesterolemia-trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?. Atherosclerosis 2013, 226:315-320.
7. Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J.Clin. Endocrinol. Metab. 2012, 97:3956-3964.
8. Kronenberg F., Utermann G. Lipoprotein(a): resurrected by genetics. J.Intern. Med. 2013, 273:6-30.
9. Jansen A.C., van Aalst-Cohen E.S., Tanck M.W., et al. The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients. J.Intern. Med. 2004, 256:482-490.
10. Seed M., Hoppichler F., Reaveley D., et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N.Engl. J. Med. 1990, 322:1494-1499.
11. Bos S., Yayha R., van Lennep J.E. Latest developments in the treatment of lipoprotein (a). Curr. Opin. Lipidol. 2014, 25:452-460.
12. Belcaro G., Nicolaides A.N., Ramaswami G., et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). Atherosclerosis 2001, 156:379-387.
13. Bots M.L., Hoes A.W., Koudstaal P.J., et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997, 96:1432-1437.
14. Burke G.L., Evans G.W., Riley W.A., et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis risk in communities (ARIC) study. Stroke 1995, 26:386-391.
15. Polak J.F., Szklo M., Kronmal R.A., et al. The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis. J.Am. Heart Assoc. 2013, 2:e000087.
16. Schreiner P.J., Morrisett J.D., Sharrett A.R., et al. Lipoprotein[a] as a risk factor for preclinical atherosclerosis. Arterioscler. Thromb. 1993, 13:826-833.
17. Baldassarre D., Tremoli E., Franceschini G., et al. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke 1996, 27:1044-1049.
18. Nordestgaard B.G., Chapman M.J., Humphries S.E., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 2013, 34:3478-3490a.
19. Vanoli D., Lindqvist P., Wiklund U., et al. Fully automated on-screen carotid intima-media thickness measurement: a screening tool for subclinical atherosclerosis. J.Clin. Ultrasound 2013, 41:333-339.
20. Kostner G.M., Avogaro P., Cazzolato G., et al. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981, 38:51-61.
21. Nordestgaard B.G., Chapman M.J., Ray K., et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 2010, 31:2844-2853.
22. Vongpromek R., Bos S., Ten Kate G.R., et al. Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia. J.Intern. Med. 2015 Aug, 278(2):166-173. Epub 2015 Jan 5. 10.1111/joim.12335.
23. Rosvall M., Janzon L., Berglund G., et al. Incident coronary events and case fatality in relation to common carotid intima-media thickness. J.Intern. Med. 2005, 257:430-437.
24. Lavrencic A., Kosmina B., Keber I., et al. Carotid intima-media thickness in young patients with familial hypercholesterolaemia. Heart 1996, 76:321-325.
25. Grebe M.T., Schoene E., Schaefer C.A., et al. Elevated Lipoprotein(a) does not promote early atherosclerotic changes of the carotid arteries in young, healthy adults. Atherosclerosis 2007, 190:194-198.